Bluejay Diagnostics (BJDX) Accounts Payables (2020 - 2026)
Bluejay Diagnostics (BJDX) reported Accounts Payables of $220288.0 for Q1 2026, down 57.6% on a YoY basis from $519524.0 in Q1 2025, and up 2.82% sequentially from $214255.0 in Q4 2025.
Bluejay Diagnostics (BJDX) Accounts Payables (2020 - 2026) Analysis & Trends
Bluejay Diagnostics (BJDX) has 7 years of Accounts Payables data on file, last reported at $220288.0 in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables fell 57.6% year-over-year to $220288.0; the trailing twelve-month figure through Mar 2026 stood at $220288.0 (down 57.6% YoY), and the FY2025 full-year result was $214255.0, up 47.64% from the prior year.
- Accounts Payables grew to $220288.0 in Q1 2026, from $214255.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $755949.0 in Q3 2023 to a low of $108817.0 in Q2 2025.
- A 5-year average of $373320.7 and a median of $316650.0 in 2024 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables jumped 114.96% in 2022 and slumped 77.79% in 2025, its largest moves.
- Tracing BJDX's Accounts Payables over 5 years: stood at $635818.0 in 2022, then slipped by 22.7% to $491474.0 in 2023, then sank by 70.47% to $145122.0 in 2024, then surged by 47.64% to $214255.0 in 2025, then increased by 2.82% to $220288.0 in 2026.
- Business Quant data shows BJDX's Accounts Payables at $220288.0 in Q1 2026, $214255.0 in Q4 2025, and $161162.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.68 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.59 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.14 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 181.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2.33 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 3.41 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.18 Bn |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - | 220,288.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 220,288.00 |
| Dec 31, 2025 | 214,255.00 |
| Sep 30, 2025 | 161,162.00 |
| Jun 30, 2025 | 108,817.00 |
| Mar 31, 2025 | 519,524.00 |
| Dec 31, 2024 | 145,122.00 |
| Sep 30, 2024 | 316,650.00 |
| Jun 30, 2024 | 490,056.00 |
| Mar 31, 2024 | 271,825.00 |
| Dec 31, 2023 | 491,474.00 |
| Sep 30, 2023 | 755,949.00 |
| Jun 30, 2023 | 271,488.00 |
| Mar 31, 2023 | 388,045.00 |
| Dec 31, 2022 | 635,818.00 |
| Sep 30, 2022 | 443,035.00 |
| Jun 30, 2022 | 196,108.00 |
| Mar 31, 2022 | 716,836.00 |
| Dec 31, 2021 | 295,778.00 |
| Sep 30, 2021 | 242,856.00 |
| Dec 31, 2020 | 133,820.00 |